Retroperitoneal Castleman’s disease: advocating a multidisciplinary approach for a rare clinical entity
Tóm tắt
Castleman’s disease is a rare and poorly understood disease entity that may resemble more common conditions and represents a clinical challenge to the treating surgeon. In this report, we describe a case of a 61-year-old Caucasian woman with a symptomatic retroperitoneal mass. The specimen obtained from her resection contained a protuberant encapsulated mass, exhibiting microscopic features consistent with localized, unicentric Castleman’s disease. These characteristics included architectural features and immunohistochemical findings consistent with the hyaline vascular variant of Castleman’s disease. We report a very rare case of a retroperitoneal hyaline vascular type of Castleman’s disease. We discuss the diagnostic dilemma Castleman’s disease may present to the surgeon, with an emphasis on multidisciplinary management of these patients. We also review current data on pathogenesis, treatment and outcomes.
Tài liệu tham khảo
Castleman B, Iverson L, Menendez VP: Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956, 9: 822-830. 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4.
Bowne WB, Lewis JJ, Filippa DA, Niesvizky R, Brooks AD, Burt ME, Brennan MF: The management of unicentric and multicentric Castleman’s disease: a report of 16 cases and a review of the literature. Cancer. 1999, 85: 706-717. 10.1002/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7.
Bucher P, Chassot G, Zufferey G, Ris F, Huber O, Morel P: Surgical management of abdominal and retroperitoneal Castleman’s disease. World J Surg Oncol. 2005, 3: 33-10.1186/1477-7819-3-33.
Keller AR, Hochholzer L, Castleman B: Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972, 29: 670-683. 10.1002/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#.
Bonekamp D, Horton KM, Hruban RH, Fishman EK: Castleman disease: the great mimic. Radiographics. 2011, 31: 1793-1807. 10.1148/rg.316115502.
Jang SY, Kim BH, Kim JH, Ha SH, Hwang JA, Yeon JW, Kim KH, Paik SY: A case of Castleman’s disease mimicking a hepatocellular carcinoma: a case report and review of literature. Korean J Gastroenterol. 2012, 59: 53-57. 10.4166/kjg.2012.59.1.53.
Wang H, Wieczorek RL, Zenilman ME, Desoto-Lapaix F, Ghosh BC, Bowne WB: Castleman’s disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome. World J Surg Oncol. 2007, 5: 133-10.1186/1477-7819-5-133.
Cronin DM, Warnke RA: Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009, 16: 236-246. 10.1097/PAP.0b013e3181a9d4d3.
Gaba AR, Stein RS, Sweet DL, Variakojis D: Multicentric giant lymph node hyperplasia. Am J Clin Pathol. 1978, 69: 86-90.
Menke DM, Camoriano JK, Banks PM: Angiofollicular lymph node hyperplasia: a comparison of unicentric, multicentric, hyaline vascular, and plasma cell types of disease by morphometric and clinical analysis. Mod Pathol. 1992, 5: 525-530.
Powles T, Stebbing J, Bazeos A, Hatzimichael E, Mandalia S, Nelson M, Gazzard B, Bower M: The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s disease. Ann Oncol. 2009, 20: 775-779. 10.1093/annonc/mdn697.
Chen CH, Liu HC, Hung TT, Liu TP: Possible roles of Epstein-Barr virus in Castleman disease. J Cardiothorac Surg. 2009, 4: 31-10.1186/1749-8090-4-31.
Muskardin TW, Peterson BA, Molitor JA: Castleman disease and associated autoimmune disease. Curr Opin Rheumatol. 2012, 24: 76-83. 10.1097/BOR.0b013e32834db525.
Talat N, Belgaumkar AP, Schulte KM: Surgery in Castleman’s disease: a systematic review of 404 published cases. Ann Surg. 2012, 255: 677-684. 10.1097/SLA.0b013e318249dcdc.
van Rhee F, Stone K, Szmania S, Barlogie B, Singh Z: Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. Clin Adv Hematol Oncol. 2010, 8: 486-498.
Hueman MT, Herman JM, Ahuja N: Management of retroperitoneal sarcomas. Surg Clin North Am. 2008, 88: 583-597. 10.1016/j.suc.2008.03.002. vii
Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin. 2002, 52: 23-47. 10.3322/canjclin.52.1.23. Published errata appear in CA Cancer J Clin 2002, 52:181–182, and CA Cancer J Clin 2002, 52:119
Windham TC, Pisters PW: Retroperitoneal sarcomas. Cancer Control. 2005, 12: 36-43.
Strauss DC, Hayes AJ, Thomas JM: Retroperitoneal tumours: review of management. Ann R Coll Surg Engl. 2011, 93: 275-280. 10.1308/003588411X571944.
Kubota K, Kato S, Mawatari H, Iida H, Akiyama T, Fujita K, Yoneda M, Takahashi H, Inamori M, Abe Y, Kirikoshi H, Kobayashi N, Saito S, Nakajima A: Risky endoscopic ultrasonography-guided fine-needle aspiration for asymptomatic retroperitoneal tumors. Dig Endosc. 2010, 22: 144-146. 10.1111/j.1443-1661.2010.00939.x.
Strauss DC, Qureshi YA, Hayes AJ, Thway K, Fisher C, Thomas JM: The role of core needle biopsy in the diagnosis of suspected soft tissue tumours. J Surg Oncol. 2010, 102: 523-529. 10.1002/jso.21600.
Inoue Y, Nakamura H, Yamazaki K, Mizumoto S, Kokubu I, Mori H: Retroperitoneal Castleman’s tumors of hyaline vascular type: imaging study case report. Clin Imaging. 1992, 16: 239-242. 10.1016/0899-7071(92)90004-S.
Zheng X, Pan K, Cheng J, Dong L, Yang K, Wu E: Localized Castleman disease in retroperitoneum: newly discovered features by multi-detector helical CT. Abdom Imaging. 2008, 33: 489-492. 10.1007/s00261-007-9273-6.
Robert JH, Sgourdos G, Kritikos N, Didier D, Terraz S: Preoperative embolization of hypervascular Castleman’s disease of the mediastinum. Cardiovasc Intervent Radiol. 2008, 31: 186-188. 10.1007/s00270-006-0156-y.
Sanchez-Ros-Sanchez A, Infante-Cossio P, Gonzalez-Garcia A, Borrero-Martin JJ: Preoperative embolization for the treatment of cervical Castleman disease. J Craniofac Surg. 2012, 23: e257-e259. 10.1097/SCS.0b013e318251880f.
Swee W, Housseini AM, Angle JF, Jones DR, Daniel TM, Turba UC, Abdel-Gawad EA, Hagspiel KD: Preoperative embolization of Castleman’s disease using microspheres. Ann Thorac Surg. 2009, 88: 1999-2001. 10.1016/j.athoracsur.2009.05.063.
Bandera B, Ainsworth C, Shikle J, Rupard E, Roach M: Treatment of unicentric Castleman disease with neoadjuvant rituximab. Chest. 2010, 138: 1239-1241. 10.1378/chest.09-2084.
de Vries IA, van Acht MM, Demeyere T, Lybeert ML, de Zoete JP, Nieuwenhuijzen GA: Neoadjuvant radiotherapy of primary irresectable unicentric Castleman’s disease: a case report and review of the literature. Radiat Oncol. 2010, 5: 7-10.1186/1748-717X-5-7.
Marti S, Pahissa A, Guardia J, Moragas A, Bacardi R: Multicentric giant follicular lymph node hyperplasia: favorable response to radiotherapy. Cancer. 1983, 51: 808-810. 10.1002/1097-0142(19830301)51:5<808::AID-CNCR2820510510>3.0.CO;2-5.
Sethi T, Joshi K, Sharma SC, Gupta BD: Radiation therapy in the management of giant lymph node hyperplasia. Br J Radiol. 1990, 63: 648-650. 10.1259/0007-1285-63-752-648.
Veldhuis GJ, van der Leest AH, de Wolf JT, de Vries EG, Vellenga E: A case of localized Castleman’s disease with systemic involvement: treatment and pathogenetic aspects. Ann Hematol. 1996, 73: 47-50. 10.1007/s002770050201.
Weisenburger DD, DeGowin RL, Gibson P, Armitage JO: Remission of giant lymph node hyperplasia with anemia after radiotherapy. Cancer. 1979, 44: 457-462. 10.1002/1097-0142(197908)44:2<457::AID-CNCR2820440212>3.0.CO;2-4.